作者: Mituo Satake , Hideo Uchida , Yasuaki Arai , Hiroshi Anai , Hirosi Sakaguchi
DOI: 10.1007/S00270-007-9255-7
关键词: Hepatocellular carcinoma 、 Medicine 、 Transcatheter arterial chemoembolization 、 Radiology 、 Survey result 、 Local ablation 、 Lipiodol
摘要: The purpose of this study was to retrospectively clarify the current status in Japan TACE using Lipiodol together with anticancer agents treat hepatocellular carcinoma (HCC). We surveyed 4,659 (average annual total) procedures for HCC over years 2002–2004 at 17 institutions included Study Group Japan. survey six questions that were related mainly and treatment. most frequently applied among (2,310; 50%) local ablation (1,395; 30%). Five 201–300 4 101–200. used “all procedures” “90% or more” seven nine institutions, respectively. Almost all 4–6 (mean, 5) ml during tumors 5 cm diameter. In conclusion, clarified is a popular option treatment